• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对痛风患者进行综合饮食教育并不能进一步降低血清尿酸水平。

Comprehensive dietary education in treated gout patients does not further improve serum urate.

作者信息

Holland R, McGill N W

机构信息

Rheumatology Department, Westmead Hospital, Sydney, NSW, 2050, Australia.

出版信息

Intern Med J. 2015 Feb;45(2):189-94. doi: 10.1111/imj.12661.

DOI:10.1111/imj.12661
PMID:25495503
Abstract

BACKGROUND/AIM: This study aims to investigate the influence of dietary education in patients with gout on a stable dose of urate-lowering therapy (ULT).

METHODS

Males and females aged >18 years with a history of gout, receiving an appropriate and stable dose of ULT, were recruited from two tertiary hospitals and randomised into two groups. The control group received basic advice regarding the importance of compliance with therapy and the benefit of weight loss. The intervention group received comprehensive dietary advice based on the British Society of Rheumatology Guidelines. Both groups received education at baseline and 3 months. Serum urate was measured at baseline, 3 months and 6 months, and a questionnaire was completed at baseline and at 6 months. The primary outcome of the study was to compare the change in serum urate between groups.

RESULTS

Thirty patients were recruited into the study. There was no difference in serum urate between the control and intervention group at 6 months (0.29 mmol/L vs 0.29 mmol/L at baseline and 0.27 mmol/L vs 0.30 mmol/L at 6 months). The intervention group showed a statistically significant improvement in knowledge (8/13 in control group at baseline to 9/13 at 6 months vs 8/13 in intervention group at baseline to 12/13 at 6 months, P < 0.05) and self-reported dietary modification (1 in control vs 7 in intervention P < 0.05) at 6 months.

CONCLUSION

This randomised controlled trial shows that in patients on ULT, providing education on diet does not lead to any clinically significant difference in serum urate at 6 months.

摘要

背景/目的:本研究旨在调查痛风患者饮食教育对稳定剂量降尿酸治疗(ULT)的影响。

方法

从两家三级医院招募年龄>18岁、有痛风病史且接受适当稳定剂量ULT的男性和女性,随机分为两组。对照组接受关于坚持治疗的重要性和减肥益处的基本建议。干预组接受基于英国风湿病学会指南的全面饮食建议。两组在基线和3个月时接受教育。在基线、3个月和6个月时测量血清尿酸,并在基线和6个月时完成一份问卷。该研究的主要结果是比较两组之间血清尿酸的变化。

结果

30名患者被纳入研究。对照组和干预组在6个月时的血清尿酸无差异(基线时分别为0.29 mmol/L和0.29 mmol/L,6个月时分别为0.27 mmol/L和0.30 mmol/L)。干预组在6个月时的知识水平(对照组基线时13人中8人,6个月时9人;干预组基线时13人中8人,6个月时12人,P<0.05)和自我报告的饮食改变(对照组1人,干预组7人,P<0.05)有统计学显著改善。

结论

这项随机对照试验表明,对于接受ULT治疗的患者,提供饮食教育在6个月时不会导致血清尿酸出现任何具有临床意义的差异。

相似文献

1
Comprehensive dietary education in treated gout patients does not further improve serum urate.对痛风患者进行综合饮食教育并不能进一步降低血清尿酸水平。
Intern Med J. 2015 Feb;45(2):189-94. doi: 10.1111/imj.12661.
2
Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study.利纳西普(白细胞介素-1 陷阱)用于降低尿酸治疗起始时预防痛风发作:III 期随机、双盲、安慰剂对照、确证疗效研究的结果。
Arthritis Care Res (Hoboken). 2012 Oct;64(10):1462-70. doi: 10.1002/acr.21690.
3
Does starting allopurinol prolong acute treated gout? A randomized clinical trial.开始使用别嘌醇会延长急性痛风的治疗时间吗?一项随机临床试验。
J Clin Rheumatol. 2015 Apr;21(3):120-5. doi: 10.1097/RHU.0000000000000235.
4
A nurse-led, rheumatologist-assisted telemedicine intervention for dose escalation of urate-lowering therapy in gout.护士主导、风湿病专家协助的远程医疗干预在痛风中增加尿酸降低治疗剂量。
Int J Rheum Dis. 2020 Aug;23(9):1136-1144. doi: 10.1111/1756-185X.13855. Epub 2020 Jun 1.
5
Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.降尿酸药物治疗痛风的疗效及耐受性:别嘌醇治疗失败后苯溴马隆与丙磺舒的随机对照试验
Ann Rheum Dis. 2009 Jan;68(1):51-6. doi: 10.1136/ard.2007.083071. Epub 2008 Feb 4.
6
Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat.实现血清尿酸目标:别嘌醇与非布司他的对比疗效研究。
Postgrad Med. 2014 Mar;126(2):65-75. doi: 10.3810/pgm.2014.03.2741.
7
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout.一项关于痛风患者中,每日300 - 600毫克别嘌醇与每日100 - 200毫克苯溴马隆剂量递增的疗效及耐受性的随机对照试验。
Ann Rheum Dis. 2009 Jun;68(6):892-7. doi: 10.1136/ard.2008.091462. Epub 2008 Jul 16.
8
Efficacy and safety of a urate lowering regimen in primary gout.一种降尿酸治疗方案在原发性痛风中的疗效与安全性。
Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):174-80. doi: 10.1080/15257770.2013.853786.
9
Implication of nurse intervention on engagement with urate-lowering drugs: A qualitative study of participants in a RCT of nurse led care.护士干预对降尿酸药物使用的影响:一项护士主导护理 RCT 中参与者的定性研究。
Joint Bone Spine. 2019 May;86(3):357-362. doi: 10.1016/j.jbspin.2018.10.008. Epub 2018 Oct 27.
10
Effectiveness of an electronic patient-centred self-management tool for gout sufferers: a cluster randomised controlled trial protocol.一种以患者为中心的痛风患者电子自我管理工具的有效性:一项整群随机对照试验方案
BMJ Open. 2017 Oct 16;7(10):e017281. doi: 10.1136/bmjopen-2017-017281.

引用本文的文献

1
[Diagnostics and treatment of gout : S3 guideline of the German Society for Rheumatology and Clinical Immunology (DGRh, lead management) and participating professional societies: German Society for Internal Medicine (DGIM), German Society for General Medicine and Family Medicine (DEGAM), German Society for Nephrology (DGfN), German Society for Orthopaedic and Trauma Surgery (DGOU), German Society for Nutritional Medicine (DGEM), German Roentgen Society-Society for Medical Radiology (DRG), German Rheumatism League].痛风的诊断与治疗:德国风湿病与临床免疫学学会(DGRh,牵头管理)及参与的专业学会制定的S3指南:德国内科医学学会(DGIM)、德国全科医学与家庭医学学会(DEGAM)、德国肾脏病学会(DGfN)、德国骨科学与创伤外科学会(DGOU)、德国营养医学学会(DGEM)、德国放射学会 - 医学放射学学会(DRG)、德国风湿病联盟
Z Rheumatol. 2025 Jul 21. doi: 10.1007/s00393-025-01634-y.
2
[Diagnostics and treatment of gout : Short version of the German S3 guideline].[痛风的诊断与治疗:德国S3指南简版]
Z Rheumatol. 2025 Jul 21. doi: 10.1007/s00393-025-01633-z.
3
Impact of lifestyle factors and dietary patterns on serum uric acid levels and disease activity in gout: a systematic review.生活方式因素和饮食模式对痛风患者血清尿酸水平及疾病活动度的影响:一项系统综述
J Health Popul Nutr. 2025 Jul 2;44(1):223. doi: 10.1186/s41043-025-00982-4.
4
Determinants of Self-Management Behavior in Gout: A Scoping Review.痛风自我管理行为的决定因素:一项范围综述
Arthritis Care Res (Hoboken). 2025 Apr;77(4):534-544. doi: 10.1002/acr.25449. Epub 2024 Dec 15.
5
Gout Knowledge: A Survey of Australian Outpatients with Gout.痛风知识:对澳大利亚痛风门诊患者的一项调查。
Open Access Rheumatol. 2024 Jan 13;16:1-7. doi: 10.2147/OARRR.S435692. eCollection 2024.
6
[2022 Update of the Austrian Society for Rheumatology and Rehabilitation nutrition and lifestyle recommendations for patients with gout and hyperuricemia].[奥地利风湿病与康复学会2022年痛风和高尿酸血症患者营养与生活方式建议更新]
Z Rheumatol. 2023 Feb;82(1):71-81. doi: 10.1007/s00393-022-01286-2. Epub 2022 Nov 24.
7
2022 update of the Austrian Society of Rheumatology and Rehabilitation nutrition and lifestyle recommendations for patients with gout and hyperuricemia.2022 年奥地利风湿病学和康复学会更新的痛风和高尿酸血症患者营养和生活方式建议。
Wien Klin Wochenschr. 2022 Jul;134(13-14):546-554. doi: 10.1007/s00508-022-02054-7. Epub 2022 Jul 11.
8
Where Epigenetics Meets Food Intake: Their Interaction in the Development/Severity of Gout and Therapeutic Perspectives.表观遗传学与饮食摄入的碰撞:它们在痛风的发生/严重程度中的相互作用及治疗前景。
Front Immunol. 2021 Sep 17;12:752359. doi: 10.3389/fimmu.2021.752359. eCollection 2021.
9
Effects of dietary macronutrients on serum urate: results from the OmniHeart trial.膳食宏量营养素对血清尿酸的影响:来自 OmniHeart 试验的结果。
Am J Clin Nutr. 2021 Jun 1;113(6):1593-1599. doi: 10.1093/ajcn/nqaa424.
10
2020 American College of Rheumatology Guideline for the Management of Gout.2020年美国风湿病学会痛风管理指南
Arthritis Care Res (Hoboken). 2020 Jun;72(6):744-760. doi: 10.1002/acr.24180. Epub 2020 May 11.